Profile
Sothema is one of the leading pharmaceutical company in Morocco and Africa with a strong international footprint. Based on the latest available figures (2024), the company shows revenue of 2.82B, net income of 315.29M, market cap of 2.89B.
Industrie Pharmaceutique • MA0000012502
Borsalia tracks SOTHEMA with its price, intraday chart, filings, and company-linked news on the Casablanca Stock Exchange.
Sothema is one of the leading pharmaceutical company in Morocco and Africa with a strong international footprint. Based on the latest available figures (2024), the company shows revenue of 2.82B, net income of 315.29M, market cap of 2.89B.
SOTHEMA price, daily move, turnover, and session range are grouped at the top of the page for a quick public-market read.
Liquidity, spread, and turnover to judge tradability.
Peer comparisons with PROMOPHARM and Akdital and related listed names.
Company-linked filings, news, and market context around SOTHEMA.
Sothema is one of the leading pharmaceutical company in Morocco and Africa with a strong international footprint
Direct exposure to the Industrie Pharmaceutique sector.
| Company | Price | 1D change | Market cap | P/E | Liquidity |
|---|---|---|---|---|---|
| 377,00 MAD | -0.53% | 2,9 Md MAD | -- | light |
 | 1.350,00 MAD | +0.00% | 1,4 Md MAD | -- | light |
 |
Sothema est un acteur leader de l'industrie pharmaceutique au Maroc avec présence internationale. Les données publiques montrent une croissance du chiffre d’affaires 2022–2024 et une amélioration de la rentabilité (Résultat d’exploitation et résultat net en hausse). Le semestre 1 2025 affiche un EBITDA et un résultat net en progression, mais des opérations récentes (augmentation de capital) et des incohérences dans le périmètre/actions (nombre d’actions, série de prix) nécessitent vigilance. Le flottant est faible et la liquidité de marché apparait limitée dans les séries disponibles.
The SOTHEMA quote is the entry point: last price, change, range, volume, and traded value. Before drawing a quick conclusion, compare that move with liquidity, recent chart behavior, and the role of SOT within Industrie Pharmaceutique. A single move may reflect real information, but it can also come from a thin order book or a session with limited turnover.
Listed filings help explain results, releases, notices, and events that may sit behind a price move. Recent news is a monitoring signal, but the stronger workflow is to open filings, check dates, and compare the content with the page metrics. Events and dividends should be read in the same context.
The displayed shareholder structure adds governance context, but it does not replace fundamentals, valuation, and peer comparison. Use comparable companies, financial indicators, and dividend history to separate a temporarily active stock from a company whose underlying data is changing. Borsalia keeps this page informational: no target price and no personalized recommendation.
For SOT, the strongest reading follows the same order every time: price and volume, chart, filings, events, fundamentals, shareholders, then sector comparison. This routine makes company pages comparable and prevents one visible module from dominating the read. If a tab looks sparse, treat it as a verification signal: it often means a publication is missing, a data field is not exploitable, or a consistency check is still open. Keep the same checklist when comparing peers so the conclusion is based on a repeatable method.
Verified shareholder structure available for this page.
Recent official issuer documents linked to the stock.
Automated news and release monitoring.
| 1.171,00 MAD |
| -0.43% |
| 16,6 Md MAD |
| -- |
| light |
 | 1.220,00 MAD | +0.00% | 1,2 Md MAD | -- | light |
 | 129,30 MAD | -0.54% | 7,8 Md MAD | -- | light |
 | 32,80 MAD | -0.58% | 13,2 Md MAD | -- | light |
